Observational studyAdvances in therapy2018
Clinical Effectiveness of Budesonide/Formoterol Fumarate Easyhaler
Observational study in Advances in therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 16 citations in OpenAlex.
- Switching to the Dry Powder Inhaler: Disease Control with a Lower Carbon Footprint.Pulmonary therapy · 2025Article
- Effectiveness and Treatment Compliance of Salmeterol-Fluticasone EasyhalerPulmonary therapy · 2022Article
- Switching to the Dry-Powder Inhaler EasyhalerPulmonary therapy · 2021Review
- Clinical Development and Research Applications of the Chronic Obstructive Pulmonary Disease Assessment Test.American journal of respiratory and critical care medicine · 2020Article
- Today's improvement in asthma treatment: role of MART and Easyhaler.Multidisciplinary respiratory medicine · 2020Article
- Impact of Clinical Factors on Generic and Disease-Specific Quality of Life in COPD and Asthma-COPD Overlap with Exacerbations.Pulmonary medicine · 2020Article
- Effectiveness and Patient Satisfaction with Budesonide/Formoterol EasyhalerPulmonary therapy · 2019Article
- A Multicenter, Observational, Prospective Study of the Effectiveness of Switching from Budesonide/Formoterol TurbuhalerAdvances in therapy · 2019Observational
- EasyhalerDrugs in context · 2019Review
- A non-interventional switch study in adult patients with asthma or COPD on clinical effectiveness of salmeterol/fluticasone EasyhalerTherapeutic advances in respiratory diseaseArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe effectiveness of inhaled therapies can be influenced by many factors, including the type of inhaler, which may have clinical implications. We report a real-world, multicenter, open-label, non-randomized, non-interventional study conducted by 200 pulmonologists across 200 centers in Hungary. The effectiveness of budesonide/formoterol inhalation therapy in daily clinical practice, delivered via the Bufomix Easyhaler
methodsEffectiveness was assessed after 12 weeks of treatment by spirometry, the Asthma Control Test, mini-Asthma Quality of Life Questionnaire, COPD Assessment Test and modified Medical Research Council dyspnea scale. Patient satisfaction with the Bufomix Easyhaler
resultsA total of 1498 patients with obstructive airway disease were evaluated (asthma: n = 621; COPD: n = 778; ACO: n = 99), of whom 455 (30.4%) were newly diagnosed inhaler-naïve patients and 1043 (69.6%) were switching from other inhalers. Significant improvements in lung function, disease control and health-related quality of life measures (all p ≤ 0.002) were reported after 12 weeks of Bufomix Easyhaler
conclusionTwelve weeks' treatment with the Bufomix Easyhaler
fundingOrion Corp., Orion Pharma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.